DexCom, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2521311074
USD
84.75
1.73 (2.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,308.40
1,191.90
1,259.60
1,209.30
1,157.10
1,036.00
1,113.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,308.40
1,191.90
1,259.60
1,209.30
1,157.10
1,036.00
1,113.50
Raw Material Cost
478.40
403.00
466.90
461.90
468.30
447.00
457.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.00
3.10
4.20
4.70
4.70
4.70
4.90
Selling and Distribution Expenses
358.70
349.70
321.50
331.40
328.00
310.10
327.40
Other Expenses
15.00
14.22
14.40
15.28
14.35
14.05
13.46
Total Expenditure (Excl Depreciation)
990.10
898.00
936.60
950.80
944.50
902.30
924.60
Operating Profit (PBDIT) excl Other Income
318.29999999999995
293.9
323
258.5
212.60000000000002
133.7
188.9
Other Income
2.20
17.30
21.90
114.50
33.20
25.30
27.30
Operating Profit (PBDIT)
388.70
339.70
410.10
420.60
308.80
219.00
274.00
Interest
3.00
3.10
4.20
4.70
4.70
4.70
4.90
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
830.00
788.90
792.70
747.40
688.80
589.00
655.80
Depreciation
68.20
67.10
65.20
63.60
63.00
60.00
57.80
Profit Before Tax
317.50
269.50
340.70
352.30
241.10
154.30
211.30
Tax
68.40
70.00
73.40
68.50
61.30
48.90
59.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
249.10
199.50
267.30
283.80
179.80
105.40
151.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
249.10
199.50
267.30
283.80
179.80
105.40
151.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
249.10
199.50
267.30
283.80
179.80
105.40
151.70
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,621.40
2,956.90
2,746.00
2,726.10
2,573.10
2,266.60
2,102.60
Earnings per share (EPS)
0.64
0.51
0.68
0.7
0.45
0.27
0.38
Diluted Earnings per share
0.64
0.51
0.68
0.7
0.45
0.27
0.38
Operating Profit Margin (Excl OI)
24.33%
21.42%
25.64%
20.05%
18.37%
12.91%
16.96%
Gross Profit Margin
29.48%
28.24%
32.22%
34.39%
26.28%
20.69%
24.17%
PAT Margin
19.04%
16.74%
21.22%
23.47%
15.54%
10.17%
13.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 13.08% vs 15.21% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 38.54% vs 25.30% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 40.24% vs 31.18% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -36.17% vs -2.08% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of DexCom, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,308.40
1,648.60
-340.20
-20.64%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,308.40
1,648.60
-340.20
-20.64%
Raw Material Cost
478.40
360.10
118.30
32.85%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.00
0.00
3.00
Selling and Distribution Expenses
358.70
522.20
-163.50
-31.31%
Other Expenses
15.00
26.33
-11.33
-43.03%
Total Expenditure (Excl Depreciation)
990.10
1,145.60
-155.50
-13.57%
Operating Profit (PBDIT) excl Other Income
318.30
503.00
-184.70
-36.72%
Other Income
2.20
37.90
-35.70
-94.20%
Operating Profit (PBDIT)
388.70
596.00
-207.30
-34.78%
Interest
3.00
0.00
3.00
Exceptional Items
0.00
-96.10
96.10
100.00%
Gross Profit (PBDT)
830.00
1,288.50
-458.50
-35.58%
Depreciation
68.20
40.90
27.30
66.75%
Profit Before Tax
317.50
459.00
-141.50
-30.83%
Tax
68.40
78.30
-9.90
-12.64%
Provisions and contingencies
0
0
0.00
Profit After Tax
249.10
380.70
-131.60
-34.57%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
249.10
380.70
-131.60
-34.57%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
249.10
380.70
-131.60
-34.57%
Equity Capital
0
0
0.00
Face Value
0.00
1.00
0.00
Reserves
2,621.40
10,327.50
-7,706.10
-74.62%
Earnings per share (EPS)
0.64
0.66
-0.02
-3.03%
Diluted Earnings per share
0.64
0.66
-0.02
-3.03%
Operating Profit Margin (Excl OI)
24.33%
31.37%
0.00
-7.04%
Gross Profit Margin
29.48%
30.32%
0.00
-0.84%
PAT Margin
19.04%
23.09%
0.00
-4.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 130.84 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 9.77% vs -5.37% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 13.08% vs 15.21% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 24.91 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 24.86% vs -25.36% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 38.54% vs 25.30% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.65 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 19.88% vs -16.95% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 40.24% vs 31.18% in Jun 2025

Quarterly - Interest
Interest 0.30 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -3.23% vs -26.19% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -36.17% vs -2.08% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.33%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025